Compound heterozygosity for novel splice site mutations in the BPAG2/COL17A1 gene underlies generalized atrophic benign epidermolysis bullosa
- PMID: 10636730
- DOI: 10.1046/j.1523-1747.1999.00793.x
Compound heterozygosity for novel splice site mutations in the BPAG2/COL17A1 gene underlies generalized atrophic benign epidermolysis bullosa
Abstract
Generalized atrophic benign epidermolysis bullosa, GABEB (OMIM# 226650), is a nonlethal variant of epidermolysis bullosa with autosomal recessive inheritance pattern. The pathogenesis of this disorder can be caused by mutations affecting two different gene/protein systems. Most of the mutations have been identified in the BPAG2/COL17A1 gene encoding a hemidesmosomal transmembrane protein, the 180 kDa bullous pemphigoid antigen (BP180), also known as type XVII collagen. The minority of the mutations are localized in the LAMB3 gene encoding the beta3 polypeptide of laminin 5. In In this study we describe a GABEB patient who showed absent expression of BP180 in the cultured keratinocytes as well as in the skin. The patient was a compound heterozygote for two different splice site mutations, 3053-1G-->C and 3871+1G-->C, affecting the extra-cellular domain of the protein. These mutations resulted in multiple aberrant splice variants, three of them causing premature termination codons for translation. This case, dealing with out-of-frame splice site mutations in BPAG2/COL17A1, attests to the molecular heterogeneity of GABEB.
Similar articles
-
Premature termination codons are present on both alleles of the bullous pemphigoid antigen 2/type XVII collagen gene in five Austrian families with generalized atrophic benign epidermolysis bullosa.J Invest Dermatol. 1997 Apr;108(4):463-8. doi: 10.1111/1523-1747.ep12289718. J Invest Dermatol. 1997. PMID: 9077475
-
Cycloheximide facilitates the identification of aberrant transcripts resulting from a novel splice-site mutation in COL17A1 in a patient with generalized atrophic benign epidermolysis bullosa.J Invest Dermatol. 1998 Feb;110(2):165-9. doi: 10.1046/j.1523-1747.1998.00103.x. J Invest Dermatol. 1998. PMID: 9457913
-
The 97 kDa linear IgA bullous dermatosis antigen is not expressed in a patient with generalized atrophic benign epidermolysis bullosa with a novel homozygous G258X mutation in COL17A1.J Invest Dermatol. 1998 Nov;111(5):887-92. doi: 10.1046/j.1523-1747.1998.00363.x. J Invest Dermatol. 1998. PMID: 9804354
-
Generalized atrophic benign epidermolysis bullosa.Adv Dermatol. 1997;13:87-119; discussion 120. Adv Dermatol. 1997. PMID: 9551142 Review.
-
Hemidesmosomal variants of epidermolysis bullosa. Mutations in the alpha6beta4 integrin and the 180-kD bullous pemphigoid antigen/type XVII collagen genes.Exp Dermatol. 1998 Apr-Jun;7(2-3):46-64. doi: 10.1111/j.1600-0625.1998.tb00304.x. Exp Dermatol. 1998. PMID: 9583744 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
